Title | Description |
|---|---|
| Trial ID | HP0151Y/09 |
| Compound | Axomadol |
| Trials sponsor | Grünenthal GmbH |
| Trial phase | 1 |
| Brief title | A Clinical Study in Healthy Subjects Which Aims to Investigate the Safety, the Tolerability and the Effects of GRT0151Y and How the Compound is Taken up and Excreted From the Body |
| Indication | |
| UTN | |
| CTG ID | NCT03761407 |
| CTIS ID (former EudraCT) | |
| Trial status | Completed |
| FPI | December 30, 2004 |
| LPO | July 26, 2005 |
| Countries | Canada |
| Gender | Male |
| Age | |
| Results | No |
| Pubmed | |
| Documents |
External Link
You are now leaving the Grünenthal website. You will be re-directed to an external website. Grünenthal accepts no responsibility for the content of other websites.